Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

10.79USD
17 Jun 2019
Change (% chg)

$0.39 (+3.75%)
Prev Close
$10.40
Open
$10.51
Day's High
$10.88
Day's Low
$10.47
Volume
178,518
Avg. Vol
175,861
52-wk High
$27.19
52-wk Low
$8.94

About

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. Its pipeline is focused on the development... (more)

Overall

Beta: 0.53
Market Cap(Mil.): $471.24
Shares Outstanding(Mil.): 45.31
Dividend: --
Yield (%): --

Financials

  CTMX.OQ Industry Sector
P/E (TTM): -- 103.12 37.45
EPS (TTM): -1.91 -- --
ROI: -25.41 7.69 12.16
ROE: -96.66 8.19 16.93

Earnings vs. Estimates